Skip to main content
. 2021 Aug 31;22(9):735–745. doi: 10.2174/1389200222666210831125041

Fig. (3).

Fig. (3)

Metabolomic analysis of GA-607-versus vehicle-treated EL4 tumors. GA-607 treatment caused an increase in FGAR, glucose, glutamine, and uridine 5′-diphospho-N-acetylglucosamine in the tumor and a decrease in succinate, aspartate, and nucleotide diphosphates. (A higher resolution / color version of this figure is available in the electronic copy of the article).